Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
ONCOLYTIC VACCINIA VIRUS HAVING LONG GENE DELETION
Document Type and Number:
WIPO Patent Application WO/2022/071559
Kind Code:
A1
Abstract:
Provided are: a vaccinia virus which can be proliferated specifically in a cancer cell to injure the cancer cell; and a use of the virus in a cancer therapy. This vaccinia virus is an oncolytic vaccinia virus in which a region composed of 7000 to 9000 base pairs contained in the genome sequence for the vaccinia virus is deleted so that the vaccinia virus cannot proliferate in a normal cell but can proliferate specifically in a cancer cell to injure the cancer cell specifically.

Inventors:
NAKAMURA TAKAFUMI (JP)
KUWANO NOZOMI (JP)
NAKATAKE MOTOMU (JP)
KOUNO HIROMICHI (JP)
Application Number:
PCT/JP2021/036371
Publication Date:
April 07, 2022
Filing Date:
October 01, 2021
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
NAT UNIV CORP TOTTORI UNIV (JP)
EVOLVE BIOTHERAPEUTICS CO LTD (JP)
International Classes:
C12N7/00; A61K35/768; A61K39/00; A61K48/00; A61P31/04; A61P31/12; A61P33/02; A61P35/00; A61P37/04; C12N7/01; C12N15/863
Foreign References:
JP2014513938A2014-06-19
Attorney, Agent or Firm:
HIRAKI & ASSOCIATES (JP)
Download PDF: